链激酶

Streptokinase is often used as a thrombolytic agent in the treatment of myocardial infarction.
溶栓药链激酶常用于心肌梗死的治疗。
The patient was administered streptokinase to dissolve a blood clot in their coronary artery.
为溶解患者冠状动脉中的血栓，给病人注射了链激酶。
In acute ischemic stroke, intravenous streptokinase can be given within 4.5 hours of symptom onset.
在急性缺血性脑卒中情况下，可在症状出现后4.5小时内静脉给予链激酶。
Streptokinase has the ability to activate plasminogen and thus break down fibrin clots.
链激酶具有激活纤溶酶原的能力，从而分解纤维蛋白血栓。
The efficacy of streptokinase for treating deep vein thrombosis is well documented in medical literature.
链激酶对于治疗深静脉血栓的疗效在医学文献中有详尽记载。
Despite its effectiveness, streptokinase may cause allergic reactions in some patients.
尽管效果显著，链激酶在某些患者中可能引发过敏反应。
A potential side effect of streptokinase therapy includes bleeding complications due to its fibrinolytic action.
链激酶疗法的一个潜在副作用是由于其溶栓作用导致出血并发症。
The use of streptokinase should be avoided in patients with a history of cerebral hemorrhage.
对有脑出血病史的患者应避免使用链激酶。
After administering streptokinase, close monitoring of the patient's coagulation status is essential.
给患者使用链激酶后，密切监测患者的凝血状态至关重要。
Although alteplase has largely replaced streptokinase in many clinical settings, it remains an option in resource-limited environments.
尽管在许多临床环境下阿替普酶已大范围替代了链激酶，但在资源有限的环境中，链激酶仍然是一个选择。